Pharmacokinetic of a very low molecular weight heparin in chronic renal failure
- 1 August 1991
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 63 (3) , 311-317
- https://doi.org/10.1016/0049-3848(91)90134-i
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparison of the platelet pro‐aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222)British Journal of Haematology, 1987
- Heparin degradation in the endothelial cellsThrombosis Research, 1987
- Evidence for a saturable mechanism of disappearance of standard heparin in rabbitsThrombosis Research, 1987
- Low molecular weight heparin half life is prolonged in haemodialysed patientsThrombosis Research, 1986
- Hemodialysis-associated platelet activation and thrombocytopeniaThe American Journal of Medicine, 1985
- A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparationThrombosis Research, 1984
- Kinetics of intravenously administered heparin in normal humansBlood, 1982
- Clinical Pharmacokinetics of HeparinClinical Pharmacokinetics, 1980
- Catabolism of low-dose heparin in manThrombosis Research, 1979
- Correctable Factors Contributing to the Anemia of Dialysis PatientsNephron, 1977